Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on Aripiprazole for Metabolic Syndrome in TRS
NCT05766540Phase 4Unknown
- Sponsor
- AIIMS New Delhi
- Start
- Aug 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of aripiprazole in metabolic syndrome, schizophrenia, sponsored by AIIMS New Delhi. Status: unknown.
02
Drugs
aripiprazole
03
Conditions
metabolic syndromeschizophrenia
Beyond the preview
Go deeper on NCT05766540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05766540.